Comparative Study between Different Medications in Treatment of Adenoid Hypertrophy

Adenoid tissue is the major constituent of Waldeyer's ring which is physiologically natural defense mechanism of the body against inhaled allergens and microorganisms. In all children, the volume of the adenoid increases with age with a maximal volume in the age group of 5-6 years, followed by a gradual decrease in volume by the age of 8-9 years. To study the effect of different medications on size and symptoms of adenoid.This study was conducted at Otorhinolaryngology Department of Al-Zahraa University Hospital and Damietta general hospital between October 2021 and October 2022. In total, 100 patients with adenoid hypertrophy with grade 3 or4 nasopharyngeal obstructions were included in this study 58 were female and 42 were males. The age ranged from 3 to 12 years. Medical treatment for adenoid hypertrophy using anti- inflammatory and anti-allergy, medications has gained importance in the last few years because of its low prevalence of complications and general good results.Medical treatment of adenoid especially combination of (antileukotriens as montelukast, anti histaminics, local corticosteroid spray as memotasone furonate) can decrease the symptoms of adenoid hypertrophy as snoring, breathing difficulty and snoring, rhinorrhea it also decrease the size of adenoid which evaluated by radiological assessment.